🔗 Share this article

The Nobel Prize in medical science was awarded for revolutionary discoveries that illuminate how the immune system attacks dangerous pathogens while sparing the healthy tissues.

Three renowned scientists—Japan's Prof. Sakaguchi and American experts Dr. Brunkow and Dr. Ramsdell—share this honor.

Their work identified specialized "sentinels" within the immune system that remove rogue immune cells capable of attacking the organism.

The findings are now paving the way for new treatments for autoimmune diseases and cancer.

These laureates will share a monetary award worth 11m Swedish kronor.

Decisive Discoveries

"Their research has been essential for comprehending how the body's defenses operates and the reason we do not all suffer from serious self-attack conditions," stated the head of the Nobel Committee.

This team's research explain a core question: In what way does the immune system defend us from countless invaders while keeping our healthy cells intact?

The immune system uses immune cells that scan for signs of infection, including pathogens and germs it has never encountered.

Such defenders utilize detectors—known as recognition units—that are generated randomly in a vast number of combinations.

This provides the immune system the capacity to combat a wide array of invaders, but the unpredictability of the process inevitably produces white blood cells that may target the host.

Security Guards of the Body

Researchers previously knew that a portion of these harmful white blood cells were eliminated in the immune organ—where immune cells develop.

The latest Nobel Prize honors the discovery of T-reg cells—described as the immune system's "peacekeepers"—which patrol the system to disarm any immune cells that assault the healthy cells.

It is known that this process fails in autoimmune diseases such as type-1 diabetes, MS, and rheumatoid arthritis.

The prize committee stated, "The findings have laid the foundation for a novel area of research and spurred the creation of innovative treatments, for instance for tumors and immune disorders."

In malignancies, regulatory T-cells prevent the system from fighting the tumor, so studies are focused on reducing their numbers.

In self-attack disorders, trials are exploring increasing T-reg cells so the organism is not under attack. A similar approach could also be useful in minimizing the chances of organ transplant failure.

Pioneering Experiments

Prof Sakaguchi, from a Japanese institution, conducted experiments on mice that had their immune gland removed, causing autoimmune disease.

The researcher demonstrated that introducing defense cells from other mice could stop the disease—implying there was a system for blocking defenders from harming the body.

Dr. Brunkow, affiliated with the a research center in a US city, and Dr. Ramsdell, currently at Sonoma Biotherapeutics in a California city, were studying an genetic immune disorder in mice and humans that resulted in the identification of a gene vital for the way T-regs operate.

"The pioneering research has uncovered how the immune system is kept in check by T-reg cells, preventing it from mistakenly targeting the healthy cells," commented a prominent biological science specialist.

"The work is a striking example of how fundamental physiological study can have far-reaching implications for public health."